# Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction

> **NCT00786253** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 236 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Levitra (Vardenafil, BAY38-9456)
- **DRUG:** Levitra (Vardenafil, BAY38-9456)

## Key facts

- **NCT ID:** NCT00786253
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786253, "Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00786253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*